CSTL
Price
$39.41
Change
+$0.31 (+0.79%)
Updated
Dec 3 closing price
Capitalization
1.15B
90 days until earnings call
Intraday BUY SELL Signals
FEMY
Price
$0.89
Change
-$0.00 (-0.00%)
Updated
Dec 3 closing price
Capitalization
51.98M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs FEMY

Header iconCSTL vs FEMY Comparison
Open Charts CSTL vs FEMYBanner chart's image
Castle Biosciences
Price$39.41
Change+$0.31 (+0.79%)
Volume$301.74K
Capitalization1.15B
Femasys
Price$0.89
Change-$0.00 (-0.00%)
Volume$1.13M
Capitalization51.98M
CSTL vs FEMY Comparison Chart in %
CSTL
Daily Signal:
Gain/Loss:
FEMY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CSTL vs. FEMY commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a StrongBuy and FEMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CSTL: $39.11 vs. FEMY: $0.89)
Brand notoriety: CSTL and FEMY are both not notable
CSTL represents the Medical Specialties, while FEMY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CSTL: 16% vs. FEMY: 5%
Market capitalization -- CSTL: $1.15B vs. FEMY: $51.98M
CSTL [@Medical Specialties] is valued at $1.15B. FEMY’s [@Pharmaceuticals: Other] market capitalization is $51.98M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $201.96B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whileFEMY’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • FEMY’s FA Score: 0 green, 5 red.
According to our system of comparison, CSTL is a better buy in the long-term than FEMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 2 TA indicator(s) are bullish while FEMY’s TA Score has 4 bullish TA indicator(s).

  • CSTL’s TA Score: 2 bullish, 4 bearish.
  • FEMY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FEMY is a better buy in the short-term than CSTL.

Price Growth

CSTL (@Medical Specialties) experienced а -2.05% price change this week, while FEMY (@Pharmaceuticals: Other) price change was -9.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.29%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +28.81%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.16%. For the same industry, the average monthly price growth was +6.95%, and the average quarterly price growth was +2.84%.

Reported Earning Dates

CSTL is expected to report earnings on Mar 04, 2026.

FEMY is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Medical Specialties (-0.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.16% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSTL($1.15B) has a higher market cap than FEMY($52M). CSTL YTD gains are higher at: 46.754 vs. FEMY (-18.891). CSTL has higher annual earnings (EBITDA): 32.6M vs. FEMY (-18.34M). CSTL has more cash in the bank: 276M vs. FEMY (3.22M). FEMY has less debt than CSTL: FEMY (7.85M) vs CSTL (37.4M). CSTL has higher revenues than FEMY: CSTL (346M) vs FEMY (1.89M).
CSTLFEMYCSTL / FEMY
Capitalization1.15B52M2,212%
EBITDA32.6M-18.34M-178%
Gain YTD46.754-18.891-247%
P/E Ratio30.24N/A-
Revenue346M1.89M18,336%
Total Cash276M3.22M8,577%
Total Debt37.4M7.85M476%
FUNDAMENTALS RATINGS
CSTL: Fundamental Ratings
CSTL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSTLFEMY
RSI
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 7 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
82%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
86%
Aroon
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CSTL
Daily Signal:
Gain/Loss:
FEMY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMERF49.05N/A
N/A
Komercni Banka A.S.
WFCL8500.00N/A
N/A
1867 Western Financial Corp
LGZDF8.65N/A
N/A
Logizard Co Ltd.
BMCLF0.25N/A
N/A
Baic Mtr Corp Ltd
TGDLF0.65N/A
N/A
TONGDAO LIEPIN GROUP

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-0.03%
TCMD - CSTL
50%
Loosely correlated
+5.06%
NTRA - CSTL
42%
Loosely correlated
+0.96%
GH - CSTL
38%
Loosely correlated
-1.28%
OFIX - CSTL
38%
Loosely correlated
-0.69%
PACB - CSTL
36%
Loosely correlated
+4.04%
More

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-0.07%
OFIX - FEMY
30%
Poorly correlated
-0.69%
CSTL - FEMY
30%
Poorly correlated
-0.03%
LUCD - FEMY
30%
Poorly correlated
N/A
OM - FEMY
29%
Poorly correlated
-3.91%
GH - FEMY
29%
Poorly correlated
-1.28%
More